Protein tyrosine phosphorylation is a crucial regulatory event in numerous signaling pathways and is controlled by the concerted and dynamic activities of protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs). Recent advances in understanding the biological functions of PTPs have revealed complex roles played by these enzymes in important cellular signaling pathways. Moreover, it has been demonstrated that alterations in the expression or activity of several PTPs are implicated in the pathogenesis of serious human diseases, such as diabetes, cancer, inflammatory and cardiovascular pathologies. Out of PTPs that aroused interest as novel drug targets, low molecular weight PTPs (LMW-PTPs) have emerged as attractive targets for designing new agents able to control postreceptor events involved in the development of metabolic and neoplastic pathologies. This Perspective focuses on recent research efforts to identify inhibitors of human LMW-PTP as potential therapeutic agents, also including an outline of the current understanding of the pathophysiological roles of LMW-PTP.

Low Molecular Weight Phosphotyrosine Protein Phosphatases as Emerging Targetsfor the Design of Novel Therapeutic Agents

MACCARI, Rosanna;OTTANA', Rosaria
2012

Abstract

Protein tyrosine phosphorylation is a crucial regulatory event in numerous signaling pathways and is controlled by the concerted and dynamic activities of protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs). Recent advances in understanding the biological functions of PTPs have revealed complex roles played by these enzymes in important cellular signaling pathways. Moreover, it has been demonstrated that alterations in the expression or activity of several PTPs are implicated in the pathogenesis of serious human diseases, such as diabetes, cancer, inflammatory and cardiovascular pathologies. Out of PTPs that aroused interest as novel drug targets, low molecular weight PTPs (LMW-PTPs) have emerged as attractive targets for designing new agents able to control postreceptor events involved in the development of metabolic and neoplastic pathologies. This Perspective focuses on recent research efforts to identify inhibitors of human LMW-PTP as potential therapeutic agents, also including an outline of the current understanding of the pathophysiological roles of LMW-PTP.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/1916000
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 27
  • ???jsp.display-item.citation.isi??? 26
social impact